BRIEF-Boehringer Ingelheim announces new post-hoc subanalysis

* New wisdom post-hoc subanalysis suggests number of people

with COPD receiving additional exacerbation risk benefit from

ICS may be smaller than previously defined

Source text for Eikon:

Read more